Copyright
©The Author(s) 2015.
World J Diabetes. Jul 10, 2015; 6(7): 912-926
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.912
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.912
Table 1 Treatment options for the management of hypoglycemia unawareness and mechanisms of action
| Treatments options | Mechanism of action |
| Optimizing insulin treatment | Avoidance of hypoglycemia |
| Pharmacological therapy | |
| β2-adrenergic agents | Enhancement of adrenaline effect |
| Methylxanthine derivates (caffeine, theophylline) | Central nervous system stimulation |
| Serotonin reuptake inhibitors (fluoxetine, sertraline, paroxetine) | Unknown. It has been hypothesized that the effect could be mediated by an atypical presentation of serotonin syndrome that will lead to autonomic dysfunction |
| KATP channel modulators | Modulation of hypoglycemia sensing |
| Other treatments | |
| Islet cell transplantation | Improving metabolic control |
| Fructose | Modulation of hypoglycemia sensing |
- Citation: Martín-Timón I, del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes 2015; 6(7): 912-926
- URL: https://www.wjgnet.com/1948-9358/full/v6/i7/912.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i7.912
